BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21963676)

  • 1. Prospects for controlling future pandemics of influenza.
    Robertson JS; Inglis SC
    Virus Res; 2011 Dec; 162(1-2):39-46. PubMed ID: 21963676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vaccines against influenza viruses.
    Kang SM; Song JM; Compans RW
    Virus Res; 2011 Dec; 162(1-2):31-8. PubMed ID: 21968298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK; Goel M; Khanna P; Mittal K
    Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy.
    Daems R; Del Giudice G; Rappuoli R
    Vaccine; 2005 Dec; 23(50):5732-42. PubMed ID: 16271423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.
    Friede M; Palkonyay L; Alfonso C; Pervikov Y; Torelli G; Wood D; Kieny MP
    Vaccine; 2011 Jul; 29 Suppl 1():A2-7. PubMed ID: 21684422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus surveillance, vaccine strain selection, and manufacture.
    Stöhr K; Bucher D; Colgate T; Wood J
    Methods Mol Biol; 2012; 865():147-62. PubMed ID: 22528158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pandemic influenza vaccine in India: from strain to sale within 12 months.
    Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S
    Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on preparing for the next influenza pandemic.
    Weber CJ
    Urol Nurs; 2006 Apr; 26(2):145-8. PubMed ID: 16703923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?
    Rudenko L; Isakova-Sivak I; Rekstin A
    Expert Rev Vaccines; 2014 Jan; 13(1):1-4. PubMed ID: 24308582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic.
    Li S; Perdue ML; Patzer E
    Dev Biol (Basel); 2002; 110():135-41. PubMed ID: 12477316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza: options to improve pandemic preparation.
    Rappuoli R; Dormitzer PR
    Science; 2012 Jun; 336(6088):1531-3. PubMed ID: 22723412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic.
    Surichan S; Wirachwong P; Supachaturas W; Utid K; Theerasurakarn S; Langsanam P; Lakornrach P; Nitisaporn L; Chansikkakorn C; Vangkanonta W; Kaweepornpoj R; Poopipatpol K; Thirapakpoomanunt S; Srichainak S; Artavatkun W; Chokevivat V; Wibulpolprasert S
    Vaccine; 2011 Jul; 29 Suppl 1():A29-33. PubMed ID: 21684425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination for pandemic influenza: a six point agenda for interpandemic years.
    Fedson DS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S74-7. PubMed ID: 14730273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of organizational structure on vaccination of first responders: a case study.
    McGuire-Wolfe C
    Am J Disaster Med; 2011; 6(2):71-2. PubMed ID: 21678817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving influenza vaccines.
    Sambhara S; Rappuoli R
    Expert Rev Vaccines; 2012 Aug; 11(8):871-2. PubMed ID: 23002964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.